Delivery Order SPE2DB22D2005-SPE2DB25FJPM7
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $6,007.90 and a completion date of July 24, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $6,007.90 and a period of performance through July 21, 2025. The contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp is a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,015.80, is for the delivery of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product, with a performance period ending on July 16, 2025. The contract is not set aside and was awarded on June 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $11,249.24 and a period of performance through October 19, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $6,007.90 and a completion date of July 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $16,873.86 and an ultimate completion date of October 2, 2024. It is a firm fixed-price contract for the delivery of these prescription drug products. The contract is not set aside for any specific business category. AmerisourceBergen, through its extensive supply chain network,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,638.02, is for the provision of TASIGNA 200 MG CAPSULE 28S, a specialty medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price arrangement. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 150 mg TASIGNA capsules, a prescription medication, with a ceiling value of $6,007.90 and a completion date of August 5, 2025. The contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a ceiling value of $6,007.90 and a period of performance through July 2, 2025. The contract is a firm fixed-price delivery order and is not a set-aside....
- This is a $6,007.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a medication, with a period of performance through April 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJPM7Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $6,007.90, and a period of performance ending on July 28, 2025. This delivery order contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/7/25 |